1. Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, et al. Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report. Occup Environ Med 2011;68:154–162.
3. Wise J. Danish night shift workers with breast cancer awarded compensation. BMJ 2009;338:b1152.
4. IARC Monographs Vol 124 group. Carcinogenicity of night shift work. Lancet Oncol 2019;20:1058–1059.
5. Brainard GC, Sliney D, Hanifin JP, Glickman G, Byrne B, Greeson JM, et al. Sensitivity of the human circadian system to short-wavelength (420-nm) light. J Biol Rhythms 2008;23:379–386.
12. Cos S, Sánchez-Barceló EJ. Melatonin and mammary pathological growth. Front Neuroendocrinol 2000;21:133–170.
13. Sánchez-Barceló EJ, Cos S, Fernández R, Mediavilla MD. Melatonin and mammary cancer: a short review. Endocr Relat Cancer 2003;10:153–159.
15. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin’s interaction with reactive species. J Pineal Res 2003;34:1–10.
16. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004;36:1–9.
18. Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L. The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev 2010;35:97–103.
20. Mormont MC, Lévi F. Circadian-system alterations during cancer processes: a review. Int J Cancer 1997;70:241–247.
21. Sephton S, Spiegel D. Circadian disruption in cancer: a neuroendocrineimmune pathway from stress to disease? Brain Behav Immun 2003;17:321–328.
22. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000;92:994–1000.
23. Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling. Mol Cell Endocrinol 2012;351:269–278.
24. Simpson ER. Biology of aromatase in the mammary gland. J Mammary Gland Biol Neoplasia 2000;5:251–258.
25. Brodie A, Lu Q, Nakamura J. Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol 1997;61:281–286.
26. Fabre B, Grosman H, Gonzalez D, Machulsky NF, Repetto EM, Mesch V, et al. Prostate cancer, high cortisol levels and complex hormonal interaction. Asian Pac J Cancer Prev 2016;17:3167–3171.
28. Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol 2016;59:651–672.
31. Thomas DB, Karagas MR. Migrant studies. In: Schottenfeld D, Fraumeni JF. editors. Cancer epidemiology and prevention (2nd ed). New York: Oxford University Press, 1996, p. 236–254.
32. Parkin DM, Khlat M. Studies of cancer in migrants: rationale and methodology. Eur J Cancer 1996;32A:761–771.
33. McCredie M. Cancer epidemiology in migrant populations. Recent Results Cancer Res 1998;154:298–305.
35. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology 2006;17:108–111.
36. Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 2012;48:1722–1729.
38. Menegaux F, Truong T, Anger A, Cordina-Duverger E, Lamkarkach F, Arveux P, et al. Night work and breast cancer: a population-based casecontrol study in France (the CECILE study). Int J Cancer 2013;132:924–931.
43. Kloog I, Portnov BA, Rennert HS, Haim A. Does the modern urbanized sleeping habitat pose a breast cancer risk? Chronobiol Int 2011;28:76–80.
45. Xiao Q, Signorello LB, Brinton LA, Cohen SS, Blot WJ, Matthews CE. Sleep duration and breast cancer risk among black and white women. Sleep Med 2016;20:25–29.
47. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res 2005;65:9595–9600.
49. McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM. Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 2006;15:241–249.
52. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 2006;66:5521–5525.
53. Wang P, Ren FM, Lin Y, Su FX, Jia WH, Su XF, et al. Night-shift work, sleep duration, daytime napping, and breast cancer risk. Sleep Med 2015;16:462–468.
54. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
56. Rao D, Yu H, Bai Y, Zheng X, Xie L. Does night-shift work increase the risk of prostate cancer? A systematic review and meta-analysis. Onco Targets Ther 2015;8:2817–2826.
62. Chang AM, Aeschbach D, Duffy JF, Czeisler CA. Evening use of lightemitting eReaders negatively affects sleep, circadian timing, and nextmorning alertness. Proc Natl Acad Sci U S A 2015;112:1232–1237.
63. Costa G, Haus E, Stevens R. Shift work and cancer-considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health 2010;36:163–179.